Adeona Executes WellZin™ Manufacturing And Supply Agreement
ANN ARBOR, Mich., Nov. 7, 2011 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN), announced today that it has executed an agreement with F&F Foods of Chicago, Illinois, to provide commercial-scale manufacturing of wellZin™, the Company's oral zinc lozenge to reduce the duration and symptoms of the common cold. Adeona is planning to commercialize wellZin, a lozenge that contains 13.3 mg of zinc acetate, based on formulations clinically tested by Ananda S. Prasad, M.D., Ph.D., a Distinguished Professor of Internal Medicine at Wayne State University School of Medicine and an Adeona Scientific Advisory Board member. wellZin is intended to be a natural, safe and effective homeopathic over-the-counter (OTC) medicine for the common cold.
In July 2011, Adeona obtained exclusive access to statistically significant clinical data from two separate studies conducted by Dr. Prasad that evaluated the effectiveness of zinc acetate lozenges on the reduction of the duration and the symptoms of the common cold. Based upon findings from Dr. Prasad's two clinical studies[i],[ii] and his expertise as a pioneer in the field of zinc, he believes that many of the zinc preparations currently available on the market include a sub-optimal formulation and/or dose of zinc, and also include flavors and binders that diminish the effectiveness of zinc treatment for the common cold. In a February 15, 2011, New York Times article that referred to the recently published Cochrane Review of zinc for the common cold, Dr. Prasad was quoted as saying, "The public is confused because people have used the wrong dose, they have used the wrong sort of zinc or they have not started the treatment within 24 hours of onset."
"I am so excited to make
wellZin commercially available for adults suffering from the symptoms of the common cold. When I notice cold symptoms coming on, it is the worst feeling and
wellZin has the potential to cut the duration and the severity of symptoms of the common cold in half if you start taking it right away," stated
James S. Kuo, M.D., M.B.A., Adeona's Chief Executive Officer. "That is why executing this agreement with F&F Foods for the manufacturing of
wellZin is so important – it brings us one step for closer to commercialization."
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV